
About CeQur
CeQur is a Healthcare company based in Horw (Switzerland) founded in 2008. Wearable insulin delivery patches are developed for mealtime dosing. CeQur has raised $491.6 million across 6 funding rounds from investors including Tandem Diabetes, Credit Suisse and Schroders. Its chief executive, as recorded, is Bradley Paddock. Its website myceqursimplicity.com draws about 59 thousand monthly visits. CeQur offers products and services including CeQur Simplicity Patch. Its focus areas include Life Sciences, Drug Delivery, Patches and Diabetes. Its legal entity is CeQur Corporation.
Company details
CeQur was founded in 2008 and is headquartered in Horw, Switzerland. Operations focus on the medical device sector, particularly diabetes management solutions. The CeQur Simplicity device, a 3-day wearable patch, is designed to deliver rapid-acting insulin subcutaneously via a built-in cannula. This enables injection-free administration of mealtime boluses under the skin for users requiring insulin therapy.
- Headquarters Horw, Switzerland
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website myceqursimplicity.com
- Social LinkedIn X YouTube
- Legal Name Cequr Corporation
- Total Equity Funding$491.6M (USD)
in 6 rounds
- Latest Funding Round$100M (USD), Series E
Jun 2026
- InvestorsTandem Diabetes
& 8 more
Products & Services of CeQur
CeQur offers a comprehensive portfolio of products and services, including CeQur Simplicity Patch.
Wearable patch for injection-free insulin delivery and glucose management.
Apps and channels of CeQur
its YouTube channel CeQur Simplicity™ has 407 subscribers and 20 videos.
Videos from CeQur
The most watched videos on CeQur's YouTube channel, CeQur Simplicity™ (407 subscribers). Click a video to play it here.
More on CeQur Simplicity™.
Funding Insights of CeQur
CeQur has successfully raised a total of $491.6M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $100 million completed in June 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $491.6M
- Total Rounds 6
- Last Round Series E β $100M
- First Round $29.6M
(Jan 2010)
- Investors Count 9
All 6 funding rounds of CeQur with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2026 | $100M | Series E | β | β | β |
| Jan 2025 | $120M | Series D | β | β | β |
| Apr 2021 | $115M | Series C | β | Credit Suisse, Endeavour Vision | |
| Sep 2015 | $100M | Series C | β | Woodford Investment Management, Arthurian Life Sciences | |
| Sep 2013 | $27M | Series B | β | Endeavour Vision, VI Partners | β |
| Jan 2010 | $29.6M | Series A | β | Endeavour Vision, Schroders |
9 investors in total: 9 institutional.
Investors in CeQur
CeQur has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Tandem Diabetes, Credit Suisse and Schroders.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| arthurianlifesciences.co.uk | ||||
Endeavour Vision is focused on transformative healthcare technology investments. | endeavourvision.com | Geneva, Switzerland | ||
Early-stage venture capital is invested in US and Europe. | vipartners.ch | Altendorf, Switzerland | ||
PE firm focused on mid-market companies operating across North America | gmscap.com | Washington, Dc, United States | ||
Diversified investment portfolios are managed for clients by the firm. | 2014 | woodfordfunds.com | Swindon, United Kingdom | |
Investment management and wealth management services are provided to clients. | 1804 | schroders.com | London, United Kingdom | |
Wealth management, asset management, and investment banking services are offered. | 1856 | credit-suisse.com | Zurich, Switzerland | |
Developer of devices for continuous glucose monitoring and manual insulin delivery | 2008 | tandemdiabetes.com | San Diego, United States | |
Self-injection systems and diabetes care products are developed and manufactured. | 2001 | ypsomed.com | Burgdorf, Switzerland |
Investor details for CeQur
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of CeQur
1 people are tracked at CeQur (1 in leadership).
| Name | Role | Group |
|---|---|---|
Bradley Paddock | CEO & President | Leadership |
Complete people profiles for CeQur
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of CeQur
3 dated milestones of CeQur across 18 years, from founding to its latest funding, stage changes and deals.
- Founded CeQur is founded.
- Funding First funding round of $29.6M.
- Funding Latest funding round, Series E, of $100.0M.
Web traffic of CeQur
The website of CeQur (myceqursimplicity.com) receives about 59.5K visits a month.
- Monthly visits59.5K
▲ 78.4% vs previous month
Websites whose visitors overlap most with CeQur. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| afrezza.com | 100% | #491,768 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cequr
Complete news archive for CeQur
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CeQur
CeQur was founded in 2008 and raised its 1st funding round 2 years after it was founded.
CeQur is headquartered in Horw, Switzerland. It is registered at Horw, Luzern, Switzerland.
Bradley Paddock is the CEO of CeQur, as recorded in our data.
CeQur is a funded company, having raised a total of $491.6M across 6 funding rounds to date. The company's 1st funding round was a Series A of $29.6M, raised on Jan 2010.
CeQur was founded in 2008 and is headquartered in Horw, Switzerland. Operations focus on the medical device sector, particularly diabetes management solutions. The CeQur Simplicity device, a 3-day wearable patch, is designed to deliver rapid-acting insulin subcutaneously via a built-in cannula. This enables injection-free administration of mealtime boluses under the skin for users requiring insulin therapy.
CeQur offers CeQur Simplicity Patch.
CeQur has 9 investors. Key investors include Tandem Diabetes, Credit Suisse, Schroders, Ypsomed, and Woodford Investment Management.
CeQur operates through Cequr Corporation.
